|
UNIVERSITY
OF VIRGINIA
BOARD OF VISITORS EXECUTIVE SUMMARY
HEALTH AFFAIRS COMMITTEE
Friday, October 15, 1999
11:45 a.m. – 12:30 p.m.
East Oval Room, The Rotunda
I.
CONSENT AGENDA
- Conflict
of Interest Exemption (Adenosine Therapeutics, LLC)
-- Approves the exemption from the Virginia Conflict of
Interest Act be granted for research contracts for developing
therapeutic agents between the University of Virginia and
"ADENOSINE THERAPEUTICS, LLC", a Virginia corporation.
II. REPORTS BY THE VICE PRESIDENT AND PROVOST FOR HEALTH SCIENCES
A.
Medical Center Financial Report (as of June 30, 1999)
-- Mr. Fitzgerald, the Health System's new Chief Financial
Officer, will report on the Medical Cneter's financial results
for Fiscal Year 1998-1999 and comment on trends observed yearto-date
this Fiscal Year.
B.
Medical Center Process Review -- Mr. Carter will review
steps underway to streamline the Medical Center's administrative
and clinical activities to effect savings.
C.
Vice President’s Remarks -- Dr. Cantrell will
report on significant developments and events impacting the
Health System that have occurred since the last meeting.
MORE MEETING INFORMATION
PAST MEETINGS
PUBLIC MINUTES
|
